OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Bupathi on First-Line Treatment Options for Clear Cell RCC

November 16th 2021

Manojkumar Bupathi, MD, MS, discusses the improvement in first-line treatment options for patients with clear cell renal cell carcinoma.

Dr. Ciombor on Anti-EGFR Therapy in Metastatic CRC

November 16th 2021

Kristen K. Ciombor, MD, MSCI, discusses the use of anti-EGFR therapy for the frontline treatment of patients with metastatic colorectal cancer.

Dr. Stephens on Early Intervention With Targeted Agents in CLL

November 15th 2021

Deborah M. Stephens, DO, discusses early intervention with targeted agents to improve outcomes in patients with high-risk chronic lymphocytic leukemia.

Dr. Langer on the Evolution of Molecular Testing in Advanced NSCLC

November 15th 2021

Corey J. Langer, MD, professor of medicine, University of Pennsylvania, director, Thoracic Oncology, Penn Medicine, discusses the evolution of molecular testing in advanced non–small cell lung cancer.

Dr. Le on the Emergence of Antibody-Drug Conjugates in NSCLC

November 15th 2021

Xiuning Le, MD, PhD, discusses the emergence of antibody-drug conjugates in non–small cell lung cancer.

Dr. Patel Discusses Novel Targets in NSCLC

November 15th 2021

Sandip P. Patel, MD, discusses novel targets in non–small cell lung cancer.

Dr. Martin on the Utility of CAR T-Cell Therapy in Late Relapsed Multiple Myeloma

November 12th 2021

Thomas G. Martin, MD, discusses the utility of CAR T-cell therapy in late relapsed multiple myeloma.

Dr. Mikhael on the Promise of Bispecific Antibodies in Multiple Myeloma

November 12th 2021

Joseph Mikhael, MD, discusses the promise of bispecific antibodies in multiple myeloma.

Dr. Lentzsch on How Patient Age Informs Treatment Decisions in Multiple Myeloma

November 12th 2021

Suzanne Lentzsch, MD, discusses how patient age informs treatment decisions in multiple myeloma.

Dr. Falkson on the Potential to De-Escalate Chemotherapy in HER2+ Breast Cancer

November 12th 2021

Carla Falkson, MBChB, MMed, MD, discusses the potential to de-escalate chemotherapy in HER2-positive breast cancer.

Dr. Stephens on Pivotal Data From ELEVATE-RR Trial in Previously Treated CLL

November 12th 2021

Deborah M. Stephens, DO, discusses the phase 3 ELEVATE-RR trial comparing the safety and efficacy of acalabrutinib with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.

Dr. Yu on the Utility of Enfortumab Vedotin in Metastatic Urothelial Cancer

November 12th 2021

Evan Y. Yu, MD, discusses the utility of enfortumab vedotin-ejfv in patients with locally advanced or metastatic urothelial cancer.

Dr. Grivas on Attempts to Improve Upon Chemotherapy in Urothelial Cancer

November 12th 2021

Petros Grivas, MD, PhD, discusses attempts to improve upon chemotherapy as a therapeutic strategy in urothelial cancer.

Dr. Vaidya on Advances in the Management of Endometrial Cancer

November 11th 2021

Ami P. Vaidya, MD, discusses advances in the management of endometrial cancer.

Dr. Michalski on the Goals ASTRO in Radiation Oncology

November 11th 2021

Jeff Michalski, MD, MBA, FASTRO, discusses the goals of the American Society for Radiation Oncology in radiation oncology.

Dr. Ivanick on the Diagnostic Role of Interventional Pulmonologists in Lung Cancer

November 11th 2021

Nathaniel Ivanick, MD, FCCP, discusses the role of interventional pulmonologists in advanced diagnostics in lung cancer.

Dr. Rimawi on Future Research Directions in Metastatic HER2+ Breast Cancer

November 11th 2021

Mothaffar Fahed Rimawi, MD, discusses future research directions in metastatic HER2-positive breast cancer.

Dr. Yentz on Unmet Needs in Metastatic RCC

November 11th 2021

Sarah Elizabeth Yentz, MD, discusses unmet needs in metastatic renal cell carcinoma.

Dr. Palmbos on the Role of Chemoimmunotherapy in Bladder Cancer

November 11th 2021

Phillip Palmbos, MD, PhD, discusses the role of chemoimmunotherapy in patients with bladder cancer.

Dr. Soares on the Standard of Care in Metastatic Pancreatic Cancer

November 11th 2021

Heloisa P. Soares, MD, PhD, discusses the standard of care in metastatic pancreatic cancer.